A012301 LoTam
Breast Cancer
A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients with Molecular Low-risk Early-Stage Breast Cancer.
Key Team Members
Principal Investigator
Research Coordinator
Katharine "Kate" Madden
MyChart Phishing Scam Warning
Lexington Health is alerting patients and community members about phishing emails that falsely use the MyChart name and logo to appear legitimate.
More Details
